Ruxolitinib acts as a selective inhibitor of CaMKII-γ to impede the progression of Bortezomib-resistant multiple myeloma through AMPK-ULK1 axis-mediated autophagy pathway
Mingdi Wang(Qufu Normal University), Chaofeng Zhang(Peking University Shougang Hospital)
Cited by 0
Related Papers
No related papers found
Powered by citation graph analysis